Shandong Lukang Pharmaceutical Co., Ltd. (hereinafter referred to as Lukang Pharmaceutical) is located in No. 88 Deyuan Road, High-tech Zone, Jining City, Shandong Province. Founded in 1966, it is a large-scale comprehensive pharmaceutical enterprise with state-owned holding. In 1997, it was listed on the main board (stock: Lukang Pharmaceutical, stock code: 600789).
With total assets of 6.6 billion yuan and more than 6,000 employees, the company has 13 joint-ownership enterprises, including 5 wholly-owned subsidiaries, 6 holding subsidiaries and 2 joint-stock companies. Qinghai Dadi Company for the production base of Tibetan medicine, Taian Saite Company for non-green non-cephalic preparation production base; Qihe Biological Pesticide Company for the production base of biological pesticides.
The main products of lukang medicine include more than 500 varieties of raw materials and preparations for human use, animal and plant drugs, including anti-infective drugs, cardio-cerebrovascular drugs, diabetes, amino acids, etc. The company has an annual production capacity of 15000 tons of various API products, 6 billion tablets/granules/bags of oral solid preparations and 2 billion pieces of powder injection preparations. The company has passed the ISO9001 quality management system certification, ISO14001 environmental management system certification and OSHMS occupational health and safety management system certification. A number of API products have passed the EU cGMP certification and the US FDA certification. Lukang products sell well all over the country and are exported to more than 50 countries and regions in Asia, Europe, Africa and America, with an annual export value of 150 million US dollars.
Anti-lu medicine has four national high and new technology enterprise, a state-level enterprise technology center, 2 provincial enterprise technology center, the shandong province engineering technology research center, built with academician workstation and post-doctoral scientific research workstation, is the "national torch plan key high-tech enterprise", the first batch of "national comprehensive new drug research and development technology platform (shandong) industrialization demonstration enterprise". In 2017, it cooperated with Tianjin Institute of Chinese Academy of Sciences to build Shandong Provincial Biotechnology Industry Transformation Platform. In 2018, the Provincial Department of Science and Technology approved the establishment of Shandong Provincial Brand International Science and Technology Cooperation Base and the establishment of Shandong University - Lukang Medical Microbiology Research Institute.
